The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy

Mahmood S Mozaffari, S. Allo, S. W. Schaffer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Adult rats exposed to 70 mg/kg streptozocin developed characteristic symptoms of overt diabetes, such as muscle wasting and severely elevated blood glucose levels. Chronic treatment of these rats with the sulfonylurea glyburide for a period of 5 weeks did not affect either the weight of the animal or the degree of hyperglycemia. The drug also failed to influence myocardial glucose metabolism. Nevertheless, the decline in myocardial function associated with the diabetic cardiomyopathy was less in the glyburide-treated rats. At higher preload, myocardial work was significantly reduced in the untreated diabetic but was only moderately depressed in the glyburide-treated heart relative to the nondiabetic heart. The improvement in mechanical function was associated with partial recovery of sarcolemmal calcium pump activity. The drug did not alter the initial rateof Na+-Ca2+ exchange, but decreased the capacity of the transport system. The results indicate that glyburide benefits the diabetic heart by a mechanism independent of carbohydrate metabolism.

Original languageEnglish (US)
Pages (from-to)1431-1436
Number of pages6
JournalCanadian Journal of Physiology and Pharmacology
Volume67
Issue number11
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Diabetic Cardiomyopathies
Glyburide
Calcium
Carbohydrate Metabolism
Therapeutics
Streptozocin
Hyperglycemia
Pharmaceutical Preparations
Blood Glucose
Weights and Measures
Glucose
Muscles

Keywords

  • Calcium
  • Cardiomyopathy
  • Diabetes
  • Heart
  • Sulfonylurea

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy. / Mozaffari, Mahmood S; Allo, S.; Schaffer, S. W.

In: Canadian Journal of Physiology and Pharmacology, Vol. 67, No. 11, 01.01.1989, p. 1431-1436.

Research output: Contribution to journalArticle

@article{84ae7c2169e1404ca60850ec6006f592,
title = "The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy",
abstract = "Adult rats exposed to 70 mg/kg streptozocin developed characteristic symptoms of overt diabetes, such as muscle wasting and severely elevated blood glucose levels. Chronic treatment of these rats with the sulfonylurea glyburide for a period of 5 weeks did not affect either the weight of the animal or the degree of hyperglycemia. The drug also failed to influence myocardial glucose metabolism. Nevertheless, the decline in myocardial function associated with the diabetic cardiomyopathy was less in the glyburide-treated rats. At higher preload, myocardial work was significantly reduced in the untreated diabetic but was only moderately depressed in the glyburide-treated heart relative to the nondiabetic heart. The improvement in mechanical function was associated with partial recovery of sarcolemmal calcium pump activity. The drug did not alter the initial rateof Na+-Ca2+ exchange, but decreased the capacity of the transport system. The results indicate that glyburide benefits the diabetic heart by a mechanism independent of carbohydrate metabolism.",
keywords = "Calcium, Cardiomyopathy, Diabetes, Heart, Sulfonylurea",
author = "Mozaffari, {Mahmood S} and S. Allo and Schaffer, {S. W.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1139/y89-229",
language = "English (US)",
volume = "67",
pages = "1431--1436",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "11",

}

TY - JOUR

T1 - The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy

AU - Mozaffari, Mahmood S

AU - Allo, S.

AU - Schaffer, S. W.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Adult rats exposed to 70 mg/kg streptozocin developed characteristic symptoms of overt diabetes, such as muscle wasting and severely elevated blood glucose levels. Chronic treatment of these rats with the sulfonylurea glyburide for a period of 5 weeks did not affect either the weight of the animal or the degree of hyperglycemia. The drug also failed to influence myocardial glucose metabolism. Nevertheless, the decline in myocardial function associated with the diabetic cardiomyopathy was less in the glyburide-treated rats. At higher preload, myocardial work was significantly reduced in the untreated diabetic but was only moderately depressed in the glyburide-treated heart relative to the nondiabetic heart. The improvement in mechanical function was associated with partial recovery of sarcolemmal calcium pump activity. The drug did not alter the initial rateof Na+-Ca2+ exchange, but decreased the capacity of the transport system. The results indicate that glyburide benefits the diabetic heart by a mechanism independent of carbohydrate metabolism.

AB - Adult rats exposed to 70 mg/kg streptozocin developed characteristic symptoms of overt diabetes, such as muscle wasting and severely elevated blood glucose levels. Chronic treatment of these rats with the sulfonylurea glyburide for a period of 5 weeks did not affect either the weight of the animal or the degree of hyperglycemia. The drug also failed to influence myocardial glucose metabolism. Nevertheless, the decline in myocardial function associated with the diabetic cardiomyopathy was less in the glyburide-treated rats. At higher preload, myocardial work was significantly reduced in the untreated diabetic but was only moderately depressed in the glyburide-treated heart relative to the nondiabetic heart. The improvement in mechanical function was associated with partial recovery of sarcolemmal calcium pump activity. The drug did not alter the initial rateof Na+-Ca2+ exchange, but decreased the capacity of the transport system. The results indicate that glyburide benefits the diabetic heart by a mechanism independent of carbohydrate metabolism.

KW - Calcium

KW - Cardiomyopathy

KW - Diabetes

KW - Heart

KW - Sulfonylurea

UR - http://www.scopus.com/inward/record.url?scp=0024850535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024850535&partnerID=8YFLogxK

U2 - 10.1139/y89-229

DO - 10.1139/y89-229

M3 - Article

C2 - 2560675

AN - SCOPUS:0024850535

VL - 67

SP - 1431

EP - 1436

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 11

ER -